Formulering av et lyofilisert pulver med nanopartikler av paklitaxel og humant serum albumin, med en pH i den rekonstituerte, vandige, injiserbare blandingen på mellom 5,4 og 5,8.
Antitumor formulation based on nanoparticles of paclitaxel and human serum albumin as obtained by the addition of a biocompatible acid to an aqueous albumin solution before this is mixed with paclitaxel during the nanoparticle production process, the injectable solutions of this formulation having a pH between 5.4 and 5.8 and having stability and inalterability with time.